2 followers
SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant fungal infections.
David Angulo
Calico
6 followers
Qualigen Therapeutics
3 followers
Vera Therapeutics
2 followers
Cargo
1 follower
Capricor Therapeutics
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Explore companies